APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Grade CBD Oil

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pharmaceutical Grade CBD Oil Market Outlook and Growth Opportunities 2026

Report ID 174024850431 December 2025209 pages

Choose your research edition.

Industry ResearchPharmaceutical Grade CBD Oil Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Grade CBD Oil Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Grade CBD Oil Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Grade CBD Oil Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Grade CBD Oil Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Pharmaceutical Grade CBD Oil market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pharmaceutical Grade CBD Oil is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmaceutical Grade CBD Oil is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical Grade CBD Oil is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pharmaceutical Grade CBD Oil market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pharmaceutical Grade CBD Oil market include Absolute Terps, Aphria, Cannavest, Canopy Growth Corporation, CBD American Shaman, Charlotte's Web, Emblem Cannabis Oils, ENDOCA and Folium Biosciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pharmaceutical Grade CBD Oil market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmaceutical Grade CBD Oil and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmaceutical Grade CBD Oil sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pharmaceutical Grade CBD Oil market size, projected growth trends, production technologies, key applications, and end-use industries.

Pharmaceutical Grade CBD Oil Segment by Company

Absolute Terps

Aphria

Cannavest

Canopy Growth Corporation

CBD American Shaman

Charlotte's Web

Emblem Cannabis Oils

ENDOCA

Folium Biosciences

GL Brands, Inc.

Green Road

HempLife Today

K.I.N.D. Concentrates

Kazmira

Medical Marijuana, Inc.

NuLeaf Naturals

PHARM-CBD, LLC

The Lab

Whistler

Pharmaceutical Grade CBD Oil Segment by Type

Full Spectrum CBD Oil

Broad Spectrum CBD Oil

Pharmaceutical Grade CBD Oil Segment by Application

Anxiety

Diabetes

Fibromyalgia

Others

Pharmaceutical Grade CBD Oil Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Pharmaceutical Grade CBD Oil status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Pharmaceutical Grade CBD Oil market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pharmaceutical Grade CBD Oil significant trends, drivers, influence factors in global and regions.

6. To analyze Pharmaceutical Grade CBD Oil competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Grade CBD Oil market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Grade CBD Oil and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Grade CBD Oil.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pharmaceutical Grade CBD Oil market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical Grade CBD Oil industry.

Chapter 3: Detailed analysis of Pharmaceutical Grade CBD Oil manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Pharmaceutical Grade CBD Oil in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Pharmaceutical Grade CBD Oil in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pharmaceutical Grade CBD Oil Industry Trends Table 2. Pharmaceutical Grade CBD Oil Industry Drivers Table 3. Pharmaceutical Grade CBD Oil Industry Opportunities and Challenges Table 4. Pharmaceutical Grade CBD Oil Industry Restraints Table 5. Global Pharmaceutical Grade CBD Oil Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pharmaceutical Grade CBD Oil Revenue Share by Company (2021-2026) Table 7. Global Pharmaceutical Grade CBD Oil Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Pharmaceutical Grade CBD Oil Sales Volume Share by Company (2021-2026) Table 9. Global Pharmaceutical Grade CBD Oil Average Price (US$/Kg) of Company (2021-2026) Table 10. Global Pharmaceutical Grade CBD Oil Company Ranking, (2024-2026) & (USD Million) Table 11. Global Pharmaceutical Grade CBD Oil Key Company Manufacturing Base & Headquarters Table 12. Global Pharmaceutical Grade CBD Oil Company, Product Type & Application Table 13. Global Pharmaceutical Grade CBD Oil Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Pharmaceutical Grade CBD Oil by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Full Spectrum CBD Oil Table 18. Significant Companies of Broad Spectrum CBD Oil Table 19. Global Pharmaceutical Grade CBD Oil Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 20. Global Pharmaceutical Grade CBD Oil Sales Volume by Type (2021-2026) & (Tons) Table 21. Global Pharmaceutical Grade CBD Oil Sales Volume by Type (2027-2032) & (Tons) Table 22. Global Pharmaceutical Grade CBD Oil Sales Volume Share by Type (2021-2026) Table 23. Global Pharmaceutical Grade CBD Oil Sales Volume Share by Type (2027-2032) Table 24. Global Pharmaceutical Grade CBD Oil Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Pharmaceutical Grade CBD Oil Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Pharmaceutical Grade CBD Oil Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Pharmaceutical Grade CBD Oil Sales Value Share by Type (2021-2026) Table 28. Global Pharmaceutical Grade CBD Oil Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Anxiety Table 30. Significant Companies of Diabetes Table 31. Significant Companies of Fibromyalgia Table 32. Significant Companies of Others Table 33. Global Pharmaceutical Grade CBD Oil Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 34. Global Pharmaceutical Grade CBD Oil Sales Volume by Application (2021-2026) & (Tons) Table 35. Global Pharmaceutical Grade CBD Oil Sales Volume by Application (2027-2032) & (Tons) Table 36. Global Pharmaceutical Grade CBD Oil Sales Volume Share by Application (2021-2026) Table 37. Global Pharmaceutical Grade CBD Oil Sales Volume Share by Application (2027-2032) Table 38. Global Pharmaceutical Grade CBD Oil Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Pharmaceutical Grade CBD Oil Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Pharmaceutical Grade CBD Oil Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Pharmaceutical Grade CBD Oil Sales Value Share by Application (2021-2026) Table 42. Global Pharmaceutical Grade CBD Oil Sales Value Share by Application (2027-2032) Table 43. Global Pharmaceutical Grade CBD Oil Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 44. Global Pharmaceutical Grade CBD Oil Sales by Region (2021-2026) & (Tons) Table 45. Global Pharmaceutical Grade CBD Oil Sales Market Share by Region (2021-2026) Table 46. Global Pharmaceutical Grade CBD Oil Sales by Region (2027-2032) & (Tons) Table 47. Global Pharmaceutical Grade CBD Oil Sales Market Share by Region (2027-2032) Table 48. Global Pharmaceutical Grade CBD Oil Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Pharmaceutical Grade CBD Oil Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Pharmaceutical Grade CBD Oil Sales Value Share by Region (2021-2026) Table 51. Global Pharmaceutical Grade CBD Oil Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Pharmaceutical Grade CBD Oil Sales Value Share by Region (2027-2032) Table 53. Global Pharmaceutical Grade CBD Oil Market Average Price (US$/Kg) by Region (2021-2026) Table 54. Global Pharmaceutical Grade CBD Oil Market Average Price (US$/Kg) by Region (2027-2032) Table 55. Global Pharmaceutical Grade CBD Oil Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 56. Global Pharmaceutical Grade CBD Oil Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Pharmaceutical Grade CBD Oil Sales by Country (2021-2026) & (Tons) Table 58. Global Pharmaceutical Grade CBD Oil Sales Market Share by Country (2021-2026) Table 59. Global Pharmaceutical Grade CBD Oil Sales by Country (2027-2032) & (Tons) Table 60. Global Pharmaceutical Grade CBD Oil Sales Market Share by Country (2027-2032) Table 61. Global Pharmaceutical Grade CBD Oil Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Pharmaceutical Grade CBD Oil Sales Value Market Share by Country (2021-2026) Table 63. Global Pharmaceutical Grade CBD Oil Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Pharmaceutical Grade CBD Oil Sales Value Market Share by Country (2027-2032) Table 65. Absolute Terps Company Information Table 66. Absolute Terps Business Overview Table 67. Absolute Terps Pharmaceutical Grade CBD Oil Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 68. Absolute Terps Pharmaceutical Grade CBD Oil Product Portfolio Table 69. Absolute Terps Recent Development Table 70. Aphria Company Information Table 71. Aphria Business Overview Table 72. Aphria Pharmaceutical Grade CBD Oil Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 73. Aphria Pharmaceutical Grade CBD Oil Product Portfolio Table 74. Aphria Recent Development Table 75. Cannavest Company Information Table 76. Cannavest Business Overview Table 77. Cannavest Pharmaceutical Grade CBD Oil Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 78. Cannavest Pharmaceutical Grade CBD Oil Product Portfolio Table 79. Cannavest Recent Development Table 80. Canopy Growth Corporation Company Information Table 81. Canopy Growth Corporation Business Overview Table 82. Canopy Growth Corporation Pharmaceutical Grade CBD Oil Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 83. Canopy Growth Corporation Pharmaceutical Grade CBD Oil Product Portfolio Table 84. Canopy Growth Corporation Recent Development Table 85. CBD American Shaman Company Information Table 86. CBD American Shaman Business Overview Table 87. CBD American Shaman Pharmaceutical Grade CBD Oil Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 88. CBD American Shaman Pharmaceutical Grade CBD Oil Product Portfolio Table 89. CBD American Shaman Recent Development Table 90. Charlotte's Web Company Information Table 91. Charlotte's Web Business Overview Table 92. Charlotte's Web Pharmaceutical Grade CBD Oil Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 93. Charlotte's Web Pharmaceutical Grade CBD Oil Product Portfolio Table 94. Charlotte's Web Recent Development Table 95. Emblem Cannabis Oils Company Information Table 96. Emblem Cannabis Oils Business Overview Table 97. Emblem Cannabis Oils Pharmaceutical Grade CBD Oil Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 98. Emblem Cannabis Oils Pharmaceutical Grade CBD Oil Product Portfolio Table 99. Emblem Cannabis Oils Recent Development Table 100. ENDOCA Company Information Table 101. ENDOCA Business Overview Table 102. ENDOCA Pharmaceutical Grade CBD Oil Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 103. ENDOCA Pharmaceutical Grade CBD Oil Product Portfolio Table 104. ENDOCA Recent Development Table 105. Folium Biosciences Company Information Table 106. Folium Biosciences Business Overview Table 107. Folium Biosciences Pharmaceutical Grade CBD Oil Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 108. Folium Biosciences Pharmaceutical Grade CBD Oil Product Portfolio Table 109. Folium Biosciences Recent Development Table 110. GL Brands, Inc. Company Information Table 111. GL Brands, Inc. Business Overview Table 112. GL Brands, Inc. Pharmaceutical Grade CBD Oil Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 113. GL Brands, Inc. Pharmaceutical Grade CBD Oil Product Portfolio Table 114. GL Brands, Inc. Recent Development Table 115. Green Road Company Information Table 116. Green Road Business Overview Table 117. Green Road Pharmaceutical Grade CBD Oil Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 118. Green Road Pharmaceutical Grade CBD Oil Product Portfolio Table 119. Green Road Recent Development Table 120. HempLife Today Company Information Table 121. HempLife Today Business Overview Table 122. HempLife Today Pharmaceutical Grade CBD Oil Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 123. HempLife Today Pharmaceutical Grade CBD Oil Product Portfolio Table 124. HempLife Today Recent Development Table 125. K.I.N.D. Concentrates Company Information Table 126. K.I.N.D. Concentrates Business Overview Table 127. K.I.N.D. Concentrates Pharmaceutical Grade CBD Oil Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 128. K.I.N.D. Concentrates Pharmaceutical Grade CBD Oil Product Portfolio Table 129. K.I.N.D. Concentrates Recent Development Table 130. Kazmira Company Information Table 131. Kazmira Business Overview Table 132. Kazmira Pharmaceutical Grade CBD Oil Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 133. Kazmira Pharmaceutical Grade CBD Oil Product Portfolio Table 134. Kazmira Recent Development Table 135. Medical Marijuana, Inc. Company Information Table 136. Medical Marijuana, Inc. Business Overview Table 137. Medical Marijuana, Inc. Pharmaceutical Grade CBD Oil Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 138. Medical Marijuana, Inc. Pharmaceutical Grade CBD Oil Product Portfolio Table 139. Medical Marijuana, Inc. Recent Development Table 140. NuLeaf Naturals Company Information Table 141. NuLeaf Naturals Business Overview Table 142. NuLeaf Naturals Pharmaceutical Grade CBD Oil Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 143. NuLeaf Naturals Pharmaceutical Grade CBD Oil Product Portfolio Table 144. NuLeaf Naturals Recent Development Table 145. PHARM-CBD, LLC Company Information Table 146. PHARM-CBD, LLC Business Overview Table 147. PHARM-CBD, LLC Pharmaceutical Grade CBD Oil Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 148. PHARM-CBD, LLC Pharmaceutical Grade CBD Oil Product Portfolio Table 149. PHARM-CBD, LLC Recent Development Table 150. The Lab Company Information Table 151. The Lab Business Overview Table 152. The Lab Pharmaceutical Grade CBD Oil Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 153. The Lab Pharmaceutical Grade CBD Oil Product Portfolio Table 154. The Lab Recent Development Table 155. Whistler Company Information Table 156. Whistler Business Overview Table 157. Whistler Pharmaceutical Grade CBD Oil Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 158. Whistler Pharmaceutical Grade CBD Oil Product Portfolio Table 159. Whistler Recent Development Table 160. Key Raw Materials Table 161. Raw Materials Key Suppliers Table 162. Pharmaceutical Grade CBD Oil Distributors List Table 163. Pharmaceutical Grade CBD Oil Customers List Table 164. Research Programs/Design for This Report Table 165. Authors List of This Report Table 166. Secondary Sources Table 167. Primary Sources List of Figures Figure 1. Pharmaceutical Grade CBD Oil Product Image Figure 2. Global Pharmaceutical Grade CBD Oil Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical Grade CBD Oil Sales Value (2021-2032) & (US$ Million) Figure 4. Global Pharmaceutical Grade CBD Oil Sales (2021-2032) & (Tons) Figure 5. Global Pharmaceutical Grade CBD Oil Sales Average Price (US$/Kg) & (2021-2032) Figure 6. Global Pharmaceutical Grade CBD Oil Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Full Spectrum CBD Oil Image Figure 10. Broad Spectrum CBD Oil Image Figure 11. Global Pharmaceutical Grade CBD Oil Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 12. Global Pharmaceutical Grade CBD Oil Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Pharmaceutical Grade CBD Oil Sales Volume Share by Type (2021-2032) Figure 14. Global Pharmaceutical Grade CBD Oil Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Pharmaceutical Grade CBD Oil Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Pharmaceutical Grade CBD Oil Sales Value Share by Type (2021-2032) Figure 17. Anxiety Image Figure 18. Diabetes Image Figure 19. Fibromyalgia Image Figure 20. Others Image Figure 21. Global Pharmaceutical Grade CBD Oil Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 22. Global Pharmaceutical Grade CBD Oil Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Pharmaceutical Grade CBD Oil Sales Volume Share by Application (2021-2032) Figure 24. Global Pharmaceutical Grade CBD Oil Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Pharmaceutical Grade CBD Oil Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Pharmaceutical Grade CBD Oil Sales Value Share by Application (2021-2032) Figure 27. Global Pharmaceutical Grade CBD Oil Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 28. Global Pharmaceutical Grade CBD Oil Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Pharmaceutical Grade CBD Oil Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Pharmaceutical Grade CBD Oil Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Pharmaceutical Grade CBD Oil Sales Value (2021-2032) & (US$ Million) Figure 32. North America Pharmaceutical Grade CBD Oil Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Pharmaceutical Grade CBD Oil Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Pharmaceutical Grade CBD Oil Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Pharmaceutical Grade CBD Oil Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Pharmaceutical Grade CBD Oil Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Pharmaceutical Grade CBD Oil Sales Value (2021-2032) & (US$ Million) Figure 38. South America Pharmaceutical Grade CBD Oil Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Pharmaceutical Grade CBD Oil Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Pharmaceutical Grade CBD Oil Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Pharmaceutical Grade CBD Oil Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Pharmaceutical Grade CBD Oil Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Full Spectrum CBD Oil
  • Broad Spectrum CBD Oil
Applications
  • Anxiety
  • Diabetes
  • Fibromyalgia
  • Others
Companies covered
  • Absolute Terps
  • Aphria
  • Cannavest
  • Canopy Growth Corporation
  • CBD American Shaman
  • Charlotte's Web
  • Emblem Cannabis Oils
  • ENDOCA
  • Folium Biosciences
  • GL Brands, Inc.
  • Green Road
  • HempLife Today
  • K.I.N.D. Concentrates
  • Kazmira
  • Medical Marijuana, Inc.
  • NuLeaf Naturals
  • PHARM-CBD, LLC
  • The Lab
  • Whistler

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pharmaceutical Grade CBD Oil Sales Value (2021-2032)
  4. 1.2.2 Global Pharmaceutical Grade CBD Oil Sales Volume (2021-2032)
  5. 1.2.3 Global Pharmaceutical Grade CBD Oil Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Pharmaceutical Grade CBD Oil Market Dynamics
  1. 2.1 Pharmaceutical Grade CBD Oil Industry Trends
  2. 2.2 Pharmaceutical Grade CBD Oil Industry Drivers
  3. 2.3 Pharmaceutical Grade CBD Oil Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Grade CBD Oil Industry Restraints
3 Pharmaceutical Grade CBD Oil Market by Company
  1. 3.1 Global Pharmaceutical Grade CBD Oil Company Revenue Ranking in 2025
  2. 3.2 Global Pharmaceutical Grade CBD Oil Revenue by Company (2021-2026)
  3. 3.3 Global Pharmaceutical Grade CBD Oil Sales Volume by Company (2021-2026)
  4. 3.4 Global Pharmaceutical Grade CBD Oil Average Price by Company (2021-2026)
  5. 3.5 Global Pharmaceutical Grade CBD Oil Company Ranking (2024-2026)
  6. 3.6 Global Pharmaceutical Grade CBD Oil Company Manufacturing Base and Headquarters
  7. 3.7 Global Pharmaceutical Grade CBD Oil Company Product Type and Application
  8. 3.8 Global Pharmaceutical Grade CBD Oil Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Pharmaceutical Grade CBD Oil Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Pharmaceutical Grade CBD Oil Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Pharmaceutical Grade CBD Oil Market by Type
  1. 4.1 Pharmaceutical Grade CBD Oil Type Introduction
  2. 4.1.1 Full Spectrum CBD Oil
  3. 4.1.2 Broad Spectrum CBD Oil
  4. 4.2 Global Pharmaceutical Grade CBD Oil Sales Volume by Type
  5. 4.2.1 Global Pharmaceutical Grade CBD Oil Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pharmaceutical Grade CBD Oil Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Pharmaceutical Grade CBD Oil Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Pharmaceutical Grade CBD Oil Sales Value by Type
  9. 4.3.1 Global Pharmaceutical Grade CBD Oil Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Pharmaceutical Grade CBD Oil Sales Value by Type (2021-2032)
  11. 4.3.3 Global Pharmaceutical Grade CBD Oil Sales Value Share by Type (2021-2032)
5 Pharmaceutical Grade CBD Oil Market by Application
  1. 5.1 Pharmaceutical Grade CBD Oil Application Introduction
  2. 5.1.1 Anxiety
  3. 5.1.2 Diabetes
  4. 5.1.3 Fibromyalgia
  5. 5.1.4 Others
  6. 5.2 Global Pharmaceutical Grade CBD Oil Sales Volume by Application
  7. 5.2.1 Global Pharmaceutical Grade CBD Oil Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Pharmaceutical Grade CBD Oil Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Pharmaceutical Grade CBD Oil Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Pharmaceutical Grade CBD Oil Sales Value by Application
  11. 5.3.1 Global Pharmaceutical Grade CBD Oil Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Pharmaceutical Grade CBD Oil Sales Value by Application (2021-2032)
  13. 5.3.3 Global Pharmaceutical Grade CBD Oil Sales Value Share by Application (2021-2032)
6 Pharmaceutical Grade CBD Oil Regional Sales and Value Analysis
  1. 6.1 Global Pharmaceutical Grade CBD Oil Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharmaceutical Grade CBD Oil Sales by Region (2021-2032)
  3. 6.2.1 Global Pharmaceutical Grade CBD Oil Sales by Region: 2021-2026
  4. 6.2.2 Global Pharmaceutical Grade CBD Oil Sales by Region (2027-2032)
  5. 6.3 Global Pharmaceutical Grade CBD Oil Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Pharmaceutical Grade CBD Oil Sales Value by Region (2021-2032)
  7. 6.4.1 Global Pharmaceutical Grade CBD Oil Sales Value by Region: 2021-2026
  8. 6.4.2 Global Pharmaceutical Grade CBD Oil Sales Value by Region (2027-2032)
  9. 6.5 Global Pharmaceutical Grade CBD Oil Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Pharmaceutical Grade CBD Oil Sales Value (2021-2032)
  12. 6.6.2 North America Pharmaceutical Grade CBD Oil Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Pharmaceutical Grade CBD Oil Sales Value (2021-2032)
  15. 6.7.2 Europe Pharmaceutical Grade CBD Oil Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Pharmaceutical Grade CBD Oil Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Pharmaceutical Grade CBD Oil Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Pharmaceutical Grade CBD Oil Sales Value (2021-2032)
  21. 6.9.2 South America Pharmaceutical Grade CBD Oil Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Pharmaceutical Grade CBD Oil Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Pharmaceutical Grade CBD Oil Sales Value Share by Country, 2025 VS 2032
7 Pharmaceutical Grade CBD Oil Country-level Sales and Value Analysis
  1. 7.1 Global Pharmaceutical Grade CBD Oil Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pharmaceutical Grade CBD Oil Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Pharmaceutical Grade CBD Oil Sales by Country (2021-2032)
  4. 7.3.1 Global Pharmaceutical Grade CBD Oil Sales by Country (2021-2026)
  5. 7.3.2 Global Pharmaceutical Grade CBD Oil Sales by Country (2027-2032)
  6. 7.4 Global Pharmaceutical Grade CBD Oil Sales Value by Country (2021-2032)
  7. 7.4.1 Global Pharmaceutical Grade CBD Oil Sales Value by Country (2021-2026)
  8. 7.4.2 Global Pharmaceutical Grade CBD Oil Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Pharmaceutical Grade CBD Oil Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Pharmaceutical Grade CBD Oil Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Pharmaceutical Grade CBD Oil Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Absolute Terps
  2. 8.1.1 Absolute Terps Company Information
  3. 8.1.2 Absolute Terps Business Overview
  4. 8.1.3 Absolute Terps Pharmaceutical Grade CBD Oil Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Absolute Terps Pharmaceutical Grade CBD Oil Product Portfolio
  6. 8.1.5 Absolute Terps Recent Developments
  7. 8.2 Aphria
  8. 8.2.1 Aphria Company Information
  9. 8.2.2 Aphria Business Overview
  10. 8.2.3 Aphria Pharmaceutical Grade CBD Oil Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Aphria Pharmaceutical Grade CBD Oil Product Portfolio
  12. 8.2.5 Aphria Recent Developments
  13. 8.3 Cannavest
  14. 8.3.1 Cannavest Company Information
  15. 8.3.2 Cannavest Business Overview
  16. 8.3.3 Cannavest Pharmaceutical Grade CBD Oil Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Cannavest Pharmaceutical Grade CBD Oil Product Portfolio
  18. 8.3.5 Cannavest Recent Developments
  19. 8.4 Canopy Growth Corporation
  20. 8.4.1 Canopy Growth Corporation Company Information
  21. 8.4.2 Canopy Growth Corporation Business Overview
  22. 8.4.3 Canopy Growth Corporation Pharmaceutical Grade CBD Oil Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Canopy Growth Corporation Pharmaceutical Grade CBD Oil Product Portfolio
  24. 8.4.5 Canopy Growth Corporation Recent Developments
  25. 8.5 CBD American Shaman
  26. 8.5.1 CBD American Shaman Company Information
  27. 8.5.2 CBD American Shaman Business Overview
  28. 8.5.3 CBD American Shaman Pharmaceutical Grade CBD Oil Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 CBD American Shaman Pharmaceutical Grade CBD Oil Product Portfolio
  30. 8.5.5 CBD American Shaman Recent Developments
  31. 8.6 Charlotte's Web
  32. 8.6.1 Charlotte's Web Company Information
  33. 8.6.2 Charlotte's Web Business Overview
  34. 8.6.3 Charlotte's Web Pharmaceutical Grade CBD Oil Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Charlotte's Web Pharmaceutical Grade CBD Oil Product Portfolio
  36. 8.6.5 Charlotte's Web Recent Developments
  37. 8.7 Emblem Cannabis Oils
  38. 8.7.1 Emblem Cannabis Oils Company Information
  39. 8.7.2 Emblem Cannabis Oils Business Overview
  40. 8.7.3 Emblem Cannabis Oils Pharmaceutical Grade CBD Oil Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Emblem Cannabis Oils Pharmaceutical Grade CBD Oil Product Portfolio
  42. 8.7.5 Emblem Cannabis Oils Recent Developments
  43. 8.8 ENDOCA
  44. 8.8.1 ENDOCA Company Information
  45. 8.8.2 ENDOCA Business Overview
  46. 8.8.3 ENDOCA Pharmaceutical Grade CBD Oil Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 ENDOCA Pharmaceutical Grade CBD Oil Product Portfolio
  48. 8.8.5 ENDOCA Recent Developments
  49. 8.9 Folium Biosciences
  50. 8.9.1 Folium Biosciences Company Information
  51. 8.9.2 Folium Biosciences Business Overview
  52. 8.9.3 Folium Biosciences Pharmaceutical Grade CBD Oil Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Folium Biosciences Pharmaceutical Grade CBD Oil Product Portfolio
  54. 8.9.5 Folium Biosciences Recent Developments
  55. 8.10 GL Brands, Inc.
  56. 8.10.1 GL Brands, Inc. Company Information
  57. 8.10.2 GL Brands, Inc. Business Overview
  58. 8.10.3 GL Brands, Inc. Pharmaceutical Grade CBD Oil Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 GL Brands, Inc. Pharmaceutical Grade CBD Oil Product Portfolio
  60. 8.10.5 GL Brands, Inc. Recent Developments
  61. 8.11 Green Road
  62. 8.11.1 Green Road Company Information
  63. 8.11.2 Green Road Business Overview
  64. 8.11.3 Green Road Pharmaceutical Grade CBD Oil Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Green Road Pharmaceutical Grade CBD Oil Product Portfolio
  66. 8.11.5 Green Road Recent Developments
  67. 8.12 HempLife Today
  68. 8.12.1 HempLife Today Company Information
  69. 8.12.2 HempLife Today Business Overview
  70. 8.12.3 HempLife Today Pharmaceutical Grade CBD Oil Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 HempLife Today Pharmaceutical Grade CBD Oil Product Portfolio
  72. 8.12.5 HempLife Today Recent Developments
  73. 8.13 K.I.N.D. Concentrates
  74. 8.13.1 K.I.N.D. Concentrates Company Information
  75. 8.13.2 K.I.N.D. Concentrates Business Overview
  76. 8.13.3 K.I.N.D. Concentrates Pharmaceutical Grade CBD Oil Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 K.I.N.D. Concentrates Pharmaceutical Grade CBD Oil Product Portfolio
  78. 8.13.5 K.I.N.D. Concentrates Recent Developments
  79. 8.14 Kazmira
  80. 8.14.1 Kazmira Company Information
  81. 8.14.2 Kazmira Business Overview
  82. 8.14.3 Kazmira Pharmaceutical Grade CBD Oil Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Kazmira Pharmaceutical Grade CBD Oil Product Portfolio
  84. 8.14.5 Kazmira Recent Developments
  85. 8.15 Medical Marijuana, Inc.
  86. 8.15.1 Medical Marijuana, Inc. Company Information
  87. 8.15.2 Medical Marijuana, Inc. Business Overview
  88. 8.15.3 Medical Marijuana, Inc. Pharmaceutical Grade CBD Oil Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Medical Marijuana, Inc. Pharmaceutical Grade CBD Oil Product Portfolio
  90. 8.15.5 Medical Marijuana, Inc. Recent Developments
  91. 8.16 NuLeaf Naturals
  92. 8.16.1 NuLeaf Naturals Company Information
  93. 8.16.2 NuLeaf Naturals Business Overview
  94. 8.16.3 NuLeaf Naturals Pharmaceutical Grade CBD Oil Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 NuLeaf Naturals Pharmaceutical Grade CBD Oil Product Portfolio
  96. 8.16.5 NuLeaf Naturals Recent Developments
  97. 8.17 PHARM-CBD, LLC
  98. 8.17.1 PHARM-CBD, LLC Company Information
  99. 8.17.2 PHARM-CBD, LLC Business Overview
  100. 8.17.3 PHARM-CBD, LLC Pharmaceutical Grade CBD Oil Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 PHARM-CBD, LLC Pharmaceutical Grade CBD Oil Product Portfolio
  102. 8.17.5 PHARM-CBD, LLC Recent Developments
  103. 8.18 The Lab
  104. 8.18.1 The Lab Company Information
  105. 8.18.2 The Lab Business Overview
  106. 8.18.3 The Lab Pharmaceutical Grade CBD Oil Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 The Lab Pharmaceutical Grade CBD Oil Product Portfolio
  108. 8.18.5 The Lab Recent Developments
  109. 8.19 Whistler
  110. 8.19.1 Whistler Company Information
  111. 8.19.2 Whistler Business Overview
  112. 8.19.3 Whistler Pharmaceutical Grade CBD Oil Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Whistler Pharmaceutical Grade CBD Oil Product Portfolio
  114. 8.19.5 Whistler Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pharmaceutical Grade CBD Oil Value Chain Analysis
  2. 9.1.1 Pharmaceutical Grade CBD Oil Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pharmaceutical Grade CBD Oil Sales Mode & Process
  6. 9.2 Pharmaceutical Grade CBD Oil Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pharmaceutical Grade CBD Oil Distributors
  9. 9.2.3 Pharmaceutical Grade CBD Oil Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst